Treatment of otitis externa: a controlled bacteriological-clinical evaluation.
D000085:Acetates / Q000627:therapeutic use*; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002175:Candida / Q000302:isolation & purification; D002177:Candidiasis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D009355:Neomycin / Q000627:therapeutic use; D010032:Otitis Externa / Q000188:drug therapy* / Q000382:microbiology; D011549:Pseudomonas / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000188:drug therapy*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D012996:Solutions
D000085:Acetates; D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D000644:Quaternary Ammonium Compounds; D012996:Solutions; D009355:Neomycin; D006854:Hydrocortisone